drugset / Trial / NCT02859337

Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA

NCT02859337

RandomizedCrossoverOpen-labelTreatment

Summary

Obese women are significantly more likely than their normal BMI counterparts to experience failure of orally-dosed emergency contraceptives. Our preliminary data provides evidence for testing a dose escalation strategy in an effort to provide improved efficacy from orally-dosed emergency contraceptives in obese women. More data is needed regarding emergency contraception containing ulipristal acetate. The overall project will be focused on both levonorgestrel (LNG) - and ulipristal acetate (UPA)-containing emergency contraception but this protocol registration is for the UPA aspect of the study procedures.

Timeline

Start
2017-05-30
Primary completion
2022-01-13
Completion
2023-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Ulipristal Acetate Unknown 30 mg Oral
Subject Ulipristal Acetate Unknown 60 mg Oral

Indications